abstract |
The invention relates to a morusin M derivative as a phosphodiesterase 4 inhibitor and a preparation method thereof, and specifically, the morusin M has a formula (A) ) The structure shown or a pharmaceutically acceptable salt thereof can be used as a PDE4 inhibitor to be prepared into a proper pharmaceutical dosage form for treating inflammatory diseases. Formula (A), (B) and ) |